Landmark Bancorp, Inc. (LARK) Q3 2025 Earnings Call Transcript
Net Income $4.9 million for Q3 2025, up from $3.9 million in Q3 2024, a 24.1% increase in diluted earnings per share. This increase was primarily due to growth in net interest income and prudently managed expenses.
Return on Average Assets Improved to 1.21% for Q3 2025. No specific year-over-year comparison provided.
Return on Average Equity Improved to 13.0% for Q3 2025. No specific year-over-year comparison provided.
Net Interest Income $14.1 million for Q3 2025, an increase of $411,000 compared to Q2 2025, driven by higher interest income.
Interest Income on Loans $17.8 million for Q3 2025, an increase of $597,000 from Q2 2025, due to higher average loan balances.
Net Interest Margin 3.83% for Q3 2025, steady compared to Q2 2025, and improved by 53 basis points compared to Q3 2024.
Noninterest Income $4.1 million for Q3 2025, an increase of $442,000 compared to Q2 2025, driven by gains on sales of mortgage loans and higher deposit-related fee income.
Noninterest Expense $11.3 million for Q3 2025, an increase of $290,000 compared to Q2 2025, primarily due to higher professional fees, occupancy and equipment expenses, and compensation and benefits.
Efficiency Ratio Improved to 60.7% for Q3 2025, compared to 66.5% in Q3 2024, due to growth in noninterest income and controlled expenses.
Allowance for Credit Losses $12.3 million as of September 30, 2025, representing 1.10% of gross loans. No specific year-over-year comparison provided.
Net Loan Charge-Offs $2.3 million for Q3 2025, compared to $9,000 in Q3 2024, primarily due to the resolution of a large commercial loan.
Deposits $1.3 billion as of September 30, 2025, an increase of $51.6 million compared to Q2 2025. Growth was driven by certificates of deposits, interest checking, and money market deposits.
Stockholders' Equity $155.7 million as of September 30, 2025, an increase of $7.4 million compared to Q2 2025, driven by lower net unrealized losses on investment securities and net earnings.
Book Value Per Share $26.92 as of September 30, 2025, up from $25.66 as of June 30, 2025.
Tangible Book Value Per Share $20.96 as of September 30, 2025, up 6.6% from Q2 2025 and 15.7% from Q3 2024, driven by growth in retained earnings and a reduction in accumulated other comprehensive loss.
Trade with 70% Backtested Accuracy
Analyst Views on LARK
About LARK
About the author

- Net Income Growth: Landmark Bancorp reported a net income of $4.7 million for Q4 2025, translating to diluted earnings per share of $0.77, which marks a significant increase from $3.3 million in Q4 2024, highlighting the company's robust profitability amid rising net interest income.
- Increase in Net Interest Income: The bank's net interest income reached $14.8 million in Q4, up $695,000 from the previous quarter, driven by improved asset yields and lower funding costs, thereby strengthening the company's financial position.
- Improvement in Nonperforming Loans: Nonperforming loans decreased slightly to just under $10 million, representing 0.90% of gross loans, down $3.1 million from year-end 2024, reflecting effective credit quality monitoring and risk management strategies.
- Continued Shareholder Returns: The board declared a cash dividend of $0.21 per share to be paid on February 26, 2026, marking the 98th consecutive quarterly cash dividend, which underscores the company's commitment to returning value to shareholders.
- Net Earnings Growth: Landmark Bancorp reported net earnings of $18.8 million for 2025, a 44.4% increase from $13.0 million in 2024, primarily driven by strong growth in net interest income and well-controlled non-interest expenses.
- Earnings Per Share Improvement: The diluted earnings per share for Q4 2025 was $0.77, showing a decrease from $0.81 in Q3 but a significant increase from $0.54 in the same quarter last year, reflecting ongoing improvements in profitability.
- Enhanced Capital Ratios: As of December 31, 2025, the tangible common equity to assets ratio increased to 8.03%, demonstrating robust capital management that helps bolster market confidence.
- Dividend Declaration: The Board declared a quarterly cash dividend of $0.21 per share, payable on February 26, 2026, to common stockholders of record as of February 12, 2026, highlighting the company's commitment to shareholder returns.
- Honor Recognition: Landmark Bancorp has been named one of the 24 top-performing small-cap banks in the U.S. by Piper Sandler for its 2025 SM-All Stars Class, showcasing its excellence in growth, profitability, and capital strength.
- New Member: As one of six new banks recognized this year, Landmark stands out in a competitive financial landscape, further solidifying its market position and reputation.
- Community Banking Mission: CEO Abby Wendel emphasized that this honor reflects the dedication of the team and the support of the Board, highlighting their commitment to building personalized relationships with clients as a community bank.
- Service Network Expansion: With 29 branches across 23 communities in Kansas, Landmark National Bank continues to drive local economic development, enhancing its influence in the regional market.
Validea's Growth Investor Model: Today's upgrades for Validea's Growth Investor model highlight LANDMARK BANCORP INC (LARK), which saw its rating increase from 74% to 89% based on strong fundamentals and valuation metrics.
Company Overview: Landmark Bancorp, Inc. operates as a community banking organization in Kansas, providing a range of financial services including residential and commercial loans, as well as property and casualty insurance through its subsidiary.
Martin Zweig's Investment Strategy: The strategy emphasizes growth stocks with accelerating earnings and sales growth, reasonable valuations, and low debt, with scores above 80% indicating interest in the stock.
Validea's Research Service: Validea offers investment research based on the strategies of renowned investors like Martin Zweig, aiming to provide stock analysis and model portfolios that have historically outperformed the market.

- Clinical Trial Launch: Larkspur Biosciences has initiated a Phase 1 clinical trial of LRK-4189 in healthy volunteers to evaluate its safety and pharmacokinetics, with plans to enroll approximately 40 participants, thereby laying the groundwork for subsequent patient studies.
- Targeted Therapy Innovation: As the first-in-class targeted protein degrader of PIP4K2C, LRK-4189 addresses 85% of colorectal cancer patients, signaling a significant breakthrough in treating hard-to-treat tumors and potentially transforming existing treatment paradigms.
- Biomarker Validation: Preclinical data indicate that LRK-4189 demonstrates favorable safety and measurable biomarker activity, suggesting that its application in healthy volunteers will help define biologically meaningful doses, thereby enhancing clinical efficacy.
- Cancer Adaptation Research: PIP4K2C is broadly expressed in various cancers, and Larkspur's research will delve into how cancer cells evade immune surveillance through this pathway, driving new directions in cancer treatment.

Zacks Analyst Blog Highlights: The Zacks Equity Research team featured stocks such as Broadcom, Meta Platforms, Coca-Cola, Landmark Bancorp, and Bridger Aerospace, providing insights into their recent performance and market trends.
Broadcom's Strong Performance: Broadcom has seen a significant increase in its stock value, driven by growth in AI semiconductors and successful integration with VMware, although it faces challenges with high debt levels and expected margin contraction.
Meta's Growth and AI Focus: Meta Platforms is experiencing user growth and increased engagement across its services, leveraging AI to enhance its offerings, though monetization of these AI services remains a concern.
Coca-Cola's Resilience and Challenges: Coca-Cola's stock has outperformed its industry due to effective strategies and innovation, but it faces pressures from soft volumes in key regions and currency headwinds impacting profitability.








